Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 2/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.52 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.52 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.52 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
| ▸ | HTR2C | P28335 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | HRH1 | P35367 | 1/20 | 0.52 |
| ▸ | DRD3 | P35462 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.46 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.46 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 7/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29084203 | 0.91 | HDAC1 (0.56) | HDAC1HDAC2CHRM1AKR1A1CHRM3 | |
| SCHEMBL19679638 | 0.86 | HDAC7 (0.50) | HDAC1HDAC2CHRM1AKR1A1CHRM3 | |
| SCHEMBL2021291 | 0.85 | USP2 (0.44) | HDAC1HDAC2CHRM1AKR1A1CHRM3 | |
| SCHEMBL28886256 | 0.85 | CA2 (0.55) | CA2MAPK1CA1SLC1A2SLC1A1 | |
| SCHEMBL29152650 | 0.84 | CA2 (0.53) | CA2MAPK1CA1GRIK1GRIK2 | |
| SCHEMBL1304206 | 0.83 | USP2 (0.42) | HDAC1HDAC2CHRM1AKR1A1CHRM3 | |
| Acetic Acid SCHEMBL8992551 | 0.81 | TSHR (0.41) | HDAC1HDAC2CHRM1AKR1A1CHRM3 | |
| SCHEMBL28755913 | 0.79 | CA2 (0.40) | HDAC1HDAC2CHRM1AKR1A1CHRM3 | |
| Hydrochloric Acid SCHEMBL3961856 | 0.78 | CHRM1 (0.75) | HDAC1HDAC2CHRM1AKR1A1CHRM3 | |
| SCHEMBL7598232 | 0.78 | CHRM1 (0.52) | HDAC1HDAC2CHRM1AKR1A1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9540309-B2 | Methylidene malonate process | OPTMED, INC. (US) | 2017-01-10 | — | — | US | disclosed |
| US-9487468-B2 | Methylidene malonate process | OPTMED, INC. (US) | 2016-11-08 | — | — | US | disclosed |
| US-20150203437-A1 | METHYLIDENE MALONATE PROCESS | OPTMED INC. (US) | 2015-07-23 | — | — | US | disclosed |
| US-20150183714-A1 | METHYLIDENE MALONATE PROCESS | OPTMED, INC. (US) | 2015-07-02 | — | — | US | disclosed |
| US-8993795-B2 | Methylidene malonate process | OPTMED INC (US) | 2015-03-31 | — | — | US | disclosed |
| US-8975435-B2 | Methylidene malonate process | OPTMED, INC. (US) | 2015-03-10 | — | — | US | disclosed |
| US-20130012736-A1 | METHYLIDENE MALONATE PROCESS | OPTMED, INC. (US) | 2013-01-10 | — | — | US | disclosed |
| US-20130008773-A1 | METHYLIDENE MALONATE PROCESS | OPTMED, INC. (US) | 2013-01-10 | — | — | US | disclosed |
| EP-2427423-A1 | IMPROVED METHYLIDENE MALONATE PROCESS | Optmed Inc. (US) | 2012-03-14 | — | — | EP | disclosed |
| EP-2427422-A1 | IMPROVED METHYLIDENE MALONATE PROCESS | Optmed Inc. (US) | 2012-03-14 | — | — | EP | disclosed |
| US-8106234-B2 | Methylidene malonate process | OptMed, Inc (US) | 2012-01-31 | — | — | US | disclosed |
| US-20100286439-A1 | METHYLIDENE MALONATE PROCESS | OPTMED, INC. | 2010-11-11 | — | — | US | disclosed |
| US-20100286438-A1 | METHYLIDENE MALONATE PROCESS | OPTMED, INC. | 2010-11-11 | — | — | US | disclosed |
| US-20100286433-A1 | METHYLIDENE MALONATE PROCESS | OPTMED, INC. | 2010-11-11 | — | — | US | disclosed |
| WO-2010129066-A1 | IMPROVED METHYLIDENE MALONATE PROCESS | OPTMED INC. (US) | 2010-11-11 | — | — | WO | disclosed |
| WO-2010129068-A1 | IMPROVED METHYLIDENE MALONATE PROCESS | OPTMED INC. (US) | 2010-11-11 | — | — | WO | disclosed |
| WO-2010129067-A1 | IMPROVED METHYLIDENE MALONATE PROCESS | OPTMED INC. (US) | 2010-11-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130012736-A1 | METHYLIDENE MALONATE PROCESS | MPHOSPH6, ME1, MGAM | HDAC1 2848/4885HDAC2 3392/4885CHRM1 4018/4885 |
| US-20100286439-A1 | METHYLIDENE MALONATE PROCESS | MPHOSPH6, ME1, MGAM | HDAC1 2848/4885HDAC2 3392/4885CHRM1 4018/4885 |
| US-20100286438-A1 | METHYLIDENE MALONATE PROCESS | MPHOSPH6, ME1, MGAM | HDAC1 2848/4885HDAC2 3392/4885CHRM1 4018/4885 |
| US-20100286433-A1 | METHYLIDENE MALONATE PROCESS | MMAB, ME1, MAL2 | HDAC1 3385/4885HDAC2 3776/4885CHRM1 3453/4885 |
| US-20150183714-A1 | METHYLIDENE MALONATE PROCESS | MPHOSPH6, ME1, MGAM | HDAC1 2848/4885HDAC2 3392/4885CHRM1 4018/4885 |
| US-20150203437-A1 | METHYLIDENE MALONATE PROCESS | MMAB, ME1, MAL2 | HDAC1 3385/4885HDAC2 3776/4885CHRM1 3453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.